Crossmark

Harnessing the power of natural killer cells in Lymphoma immunotherapy: Overcoming challenges and enhancing treatment options

Crossref DOI link: https://doi.org/10.1016/j.htct.2026.106352

Published Print: 2026-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Roshandel, Elham

Lasemi, Maryam Vahdat

Mehravar, Maryam https://orcid.org/0000-0003-2442-0635
Salimi, Maryam

Majidi, Mohammad

Mohammadali, Fatemeh

Seraji, Hamide Rahmani

Hajifathali, Abbas
Funding

Funding for this research was provided by:

Shahid Beheshti University
License Information

Text and Data Mining valid from 2026-07-01

Text and Data Mining valid from 2026-07-01

Version of Record valid from 2026-02-12
More Information

This article is maintained by: Elsevier

Article Title: Harnessing the power of natural killer cells in Lymphoma immunotherapy: Overcoming challenges and enhancing treatment options

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2026.106352

Content Type: article

Copyright: © 2026 Published by Elsevier España, S.L.U. on behalf of Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular.